Andrew M Wilson
Affiliation: Stanford University
- Are Australasian academic physicians an endangered species?A Wilson
Stanford University Medical Center, Stanford, California, USA
Intern Med J 37:778-81. 2007..Thus, there is a strong case to assess the problems facing recruitment and retention of physician-scientists in academic practice and to develop workable solutions...
- Successful removal of a paradoxical coronary embolus using an aspiration catheterAndrew M Wilson
Interventional Cardiology, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA
Nat Clin Pract Cardiovasc Med 3:633-6. 2006..The patient did not have a history of cardiovascular risk factors, recent travel, immobilization or clinical features of infection, and he was not taking any medication...
- Cutting balloon inflation for drug-eluting stent underexpansion due to unrecognized coronary arterial calcificationAndrew Wilson
Cardiovascular Medicine Division, Stanford University Medical Center, Stanford, CA 94305, USA
Cardiovasc Revasc Med 7:185-8. 2006..We describe the use of cutting balloon inflation within the implanted stent which overcame calcific restraint unresponsive to high pressure inflations with non-compliant balloons...
- Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophyA M Wilson
University of Melbourne, Department of Medicine, St Vincent s Hospital, Melbourne, Australia
Atherosclerosis 191:175-81. 2007..Evidence of local vascular production and a relationship between serum hsCRP levels and tissue expression of CRP in subjects with vascular disease would support a direct role for CRP in atherosclerosis...
- Impact of right atrial pressure on decision-making using fractional flow reserve (FFR) in elective percutaneous interventionJamie Layland
Department of Cardiology St Vincent s Hospital, Fitzroy, Victoria, Australia
Int J Cardiol 167:951-3. 2013..We undertook a prospective study to assess the impact of routine incorporation of right atrial pressure into the calculation of FFR in a real world elective PCI cohort...
- High incidence of insulin resistance and dysglycemia amongst nondiabetic cardiac surgical patientsSophie C Hofferberth
Department of Medicine St Vincent s, The University of Melbourne, Melbourne, Victoria, Australia
Ann Thorac Surg 94:117-22. 2012..This study assessed whether the preoperative level of insulin resistance predicts the degree of perioperative dysglycemia in nondiabetic, normoglycemic cardiac surgical patients...
- Biomarkers of peripheral arterial diseaseJohn P Cooke
Division of Cardiovascular Medicine, Stanford University, Stanford, California 94305 5406, USA
J Am Coll Cardiol 55:2017-23. 2010..Biomarkers may be derived from studies of the genome, transcriptome, proteome, or metabolome. The focus of this review is on proteomic biomarkers associated with PAD...
- Low lifetime recreational activity is a risk factor for peripheral arterial diseaseAndrew M Wilson
Department of Medicine, University of Melbourne, Melbourne, Australia
J Vasc Surg 54:427-32, 432.e1-4. 2011..The relationship between lifetime physical activity and the risk of developing peripheral arterial disease (PAD) is not known...
- Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarctionWilliam F Fearon
Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California 94305, USA
J Am Coll Cardiol 51:560-5. 2008....
- Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial diseaseAndrew M Wilson
Falk Cardiovascular Research Institute, Stanford University Medical Center, Stanford, California, USA
Vasc Med 15:267-74. 2010..Agents that target this pathway may be useful for this patient population. Clinical Trial Registration - URL: http:// www.clinicaltrials.gov. Unique identifier: NCT00284076...
- Latent plaque rupture in a patient undergoing stenting for acute coronary syndrome and diffuse coronary disease: a case report and review of literatureTomomi Koizumi
Division of Cardiovascular Medicine, Stanford University, Stanford, California, USA
Catheter Cardiovasc Interv 67:241-5. 2006..This case report describes a 53-year-old man who experienced plaque rupture between two previously successfully implanted stents in the right coronary artery, as documented during the 3rd intervention using intravascular ultrasound...
- The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver diseaseMarno C Ryan
Gastroenterology Department, St Vincent s Hospital, Melbourne, Australia
J Hepatol 59:138-43. 2013..Weight loss is of benefit but is difficult to maintain. We aimed at examining the effect of the Mediterranean diet (MD), a diet high in monounsaturated fatty acids, on steatosis and insulin sensitivity, using gold standard techniques...
- When collateral supply is accounted for epicardial stenosis does not increase microvascular resistanceJamie Layland
Department of Cardiology, St Vincent s Hospital, Fitzroy, Victoria, Melbourne, Australia
Circ Cardiovasc Interv 5:97-102. 2012..However, variable collateralization may impact well on these measures. We hypothesized that when collateral supply was accounted for, microvascular resistance would be independent of epicardial stenosis...
- Combined proximal endografting with distal bare-metal stenting for management of aortic dissectionSophie C Hofferberth
Department of Medicine, St Vincent s, The University of Melbourne, and Department of Cardiac Surgery, St Vincent s Hospital Melbourne, Fitzroy, Victoria, Australia
Ann Thorac Surg 93:95-102. 2012....
- Intravenous leiomyomatosis with intracardiac extension - a review of diagnosis and management with an illustrative caseTimothy D Clay
Department of Medical Oncology, St Vincent s Hospital, Melbourne, Australia
Surg Oncol 22:e44-52. 2013..Operative management aims to completely resect all tumour in the safest manner for the patient, most commonly via single or two stage operation. Where complete resection is achieved, recurrence appears to be a rare event. ..
- Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factorsMichael D W Griffin
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia
Clin Biochem 43:278-86. 2010..In addition, chemically modified serum components that contribute to serum ThT fluorescence were explored and identified...
- Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studiesAndrew M Wilson
Stanford University School of Medicine, Division of Cardiovascular Medicine, 300 Pasteur Dr, Falk Cardiovascular Research Center, Stanford, CA 94305 5406, USA
Circulation 116:1396-403. 2007..Peripheral arterial disease (PAD) is common but commonly unrecognized. Improved recognition of PAD is needed. We used high-throughput proteomic profiling to find PAD-associated biomarkers...
- The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogenAndrew M Wilson
University of Melbourne, Department of Medicine, St Vincent s Hospital, Princes St, Fitzroy, Melbourne, Victoria 3065, Australia
Int J Cardiol 106:291-7. 2006..We review the postulated roles of CRP in atherogenesis and prediction of vascular events, as well as discussing current recommendations for CRP testing in patients...
- L-arginine supplementation in peripheral arterial disease: no benefit and possible harmAndrew M Wilson
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, Calif 94305, USA
Circulation 116:188-95. 2007..We aimed to determine the effects of long-term administration of L-arginine on vascular reactivity and functional capacity in patients with PAD...
- Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal functionCraig L Nelson
Department of Medicine, St Vincent s Hospital, Cnr Princes and Regent Streets, Fitzroy, Vic, 3065, Australia
Nephrol Dial Transplant 20:2420-6. 2005..Inflammation is implicated in cardiovascular disease (CVD) and mortality in end-stage renal failure (ESRF). Its importance in early renal disease is yet to be defined...
- Comparison of arterial assessments in low and high vascular disease risk groupsAndrew M Wilson
University of Melbourne, Department of Medicine, St Vincent s Hospital, Melbourne, Australia
Am J Hypertens 17:285-91. 2004..We have consecutively performed these measures in subjects with low and high vascular disease risks to assess the interrelationships...
- Safety of sputum induction in moderate-to-severe smoking-related chronic obstructive pulmonary diseaseAndrew M Wilson
School of Medicine Health Policy and Practice, University of East Anglia, UK
COPD 3:89-93. 2006..Investigation of the safety of sputum induction in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) has been limited...
- Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver diseaseMarno C Ryan
Department of Medicine, 4th Floor Clinical Sciences Building, St Vincent s Hospital, 41 Victoria Parade, Fitzroy 3065 Victoria, Australia
Diabetes Care 28:1222-4. 2005